Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trial

Tien Dam, Adam L. Boxer, Lawrence I. Golbe, Günter U. Höglinger, Huw R. Morris, Irene Litvan, Anthony E. Lang, Jean‐Christophe Corvol, Ikuko Aiba, Michael Grundman, Lili Yang, Beth Tidemann‐Miller, Joseph Kupferman, Kristine D. Harper, Kubra Kamisoglu, Michael Wald, Danielle Graham, Liz Gedney, John O’Gorman, Samantha Budd Haeberlein, PASSPORT Study Group